KTN's online platform helps you to make the connections you need

 

The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.

 

The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

« go back

Capsugel Expands Capabilities at its Edinburgh Facility

Capsugel announced on July 22 an expansion that will more than double the size of its Edinburgh, Scotland facility by adding 40,000 sq ft of space. The expansion will enable the Dosage Form Solutions business unit to both increase its liquid- and semi-solid-fill hard capsule manufacturing capacity for drug products containing high-potency APIs (HPAPI) and further diversify its technology platforms offered at the facility, according to a Capsugel statement.

The first phase of the expansion includes analytical, formulation, and quality laboratories for bioavailability, HPAPI, and other formulation challenges. The second phase, which is scheduled to begin later in 2015, will expand commercial manufacturing capacity and bring the company’s other formulation and development technologies, including spray dried dispersion (SDD), to this location.

Over the past two years, the Edinburgh facility, which Capsugel acquired as part of its purchase of Encap Drug Delivery in March 2013, has experienced a 40% growth in its development services business, and established a commercial manufacturing pipeline, including eight late-stage projects in process.

The Edinburgh facility had successful inspections by the Medicines and Healthcare Products Regulatory Agency (MHRA) and the US Food and Drug Administration (FDA) in 2014. That same year, the site secured two customer project approvals with the MHRA. Earlier this year, the site collaborated with a customer to file a new drug application (NDA) registration with the FDA, and it is expecting multiple new product filings per year for the foreseeable future.